🇺🇸 FDA
Patent

US 9592180

Method and device for treating allergic reactions and difficult-to-manage respiratory diseases

granted A61KA61K31/137A61K9/0019

Quick answer

US patent 9592180 (Method and device for treating allergic reactions and difficult-to-manage respiratory diseases) held by Pharmaceutical Design, LLC expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Pharmaceutical Design, LLC
Grant date
Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/137, A61K9/0019